2009, Número 1
<< Anterior Siguiente >>
Rev Mex Cir Endoscop 2009; 10 (1)
Pancreatitis aguda severa temprana postcolangiopancreatografía retrógrada endoscópica, presentación de un caso
Murillo ZA, Vidal GP, Cárdenas SC, Robles CJ, Sarue SN
Idioma: Español
Referencias bibliográficas: 30
Paginas: 40-44
Archivo PDF: 104.75 Kb.
RESUMEN
Antecedentes: La colangiopancreatografía retrógrada endoscópica posee capacidades diagnósticas y/o terapéuticas con pocas complicaciones. Entre éstas, la más temida es la pancreatitis que ocurre en 1.8-9% de los casos. Existen varios factores de riesgo: edad joven, género femenino, sospecha de disfunción del esfínter de Oddi. Se desconoce la patogenia de esta enfermedad, pero se cree es causada por una lesión y edema de la papila y el esfínter pancreático. El uso de una endoprótesis en el conducto pancreático disminuye el riesgo de esta complicación.
Caso clínico: Femenino de 58 años que presentó dolor abdominal postprandial intermitente en hipocondrio derecho irradiado a región lumbar. Había presentado elevaciones discretas de enzimas hepáticas. Se le realizó colangiorresonancia, detectándose dilatación del colédoco que terminaba en una zona de estrechez. Se interpretó como posible disfunción del esfínter de Oddi. Se le realizó colangiopancreatografía retrógrada endoscópica (CPRE) cursando posterior a ésta con disfunción orgánica múltiple y paro cardiorrespiratorio a las 31 h del procedimiento.
Discusión: Es importante identificar pacientes con factores de riesgo de pancreatitis postcolangiopancreatografía endoscópica. De esta manera se pueden tomar medidas preventivas como la colocación de una endoprótesis para disminuir la incidencia de su presentación.
REFERENCIAS (EN ESTE ARTÍCULO)
Freeman M. Adverse outcomes of ERCP. Gastrointest Endosc 2002; 56: 273-282.
Pannu HK, Fishman EL. Complications of endoscopic retrograde cholangiopancreatography: Spectrum of abnormalities demonstrated with CT. Radiographics 2001; 21: 1441-1453.
Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A, Prada A, Passoni GR, Testoni PA. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am J Gastroenterol 2001; 96: 417-423.
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JF, Pheley AM. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-98.
Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R. Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J of Gastroenterol 2007; 102: 1781-1788.
Andriulli A, Forlano R, Napolitano G, Conoscitore P, Caruso N, Pilotto A, Di Sebastiano PL, Leandro G. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks. Digestion 2007; 75: 156-163.
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991; 37: 383-93.
Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60: 721-731.
Bhasin DK, Rana SS, Nadkarni N. Protocol-based management strategy for post-endoscopic retrograde cholangiopancreatography pancreatitis: Can it make a difference? J Gastroenterol Hepatol 2008; 23: 344-347.
Abid GH, Siriwardana HP, Holt A, Ammori BJ. Mild ERCP-induced and non-ERCP-related acute pancreatitis: two distinct clinical entities? J Gastroenterol 2007; 42: 146-151.
Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol Clin North Am 2007; 36: 259-276.
Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: A comprehensive review. Gastrointest Endosc 2004; 59: 845-863.
Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54: 425-34.
Andriulli A, Leonardo G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: An updated meta-analysis. Gastrointest Endosc 2007; 65: 624-632.
Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, Montes H, Roston AD, Slivka A, Lichtenstein DR, Ruymann FW, Van Dam J, Hughes M, Carr-Locke DL. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56: 656.
Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: Characteristics of a new subgroup. Pancreas 2001; 22: 274-278.
Tao H, Zhang J, Zou S. Clinical characteristics and management of patients with early acute severe pancreatitis: Experience from a medical center in China. World J Gastroenterol 2004; 10: 919-921.
Guitrón A, Adalid R, Gutiérrez JA, Nieves A, Álvarez G. Complicaciones en colangiopancreatografía endoscópica diagnóstica y terapéutica. Estudio prospectivo. Rev Gastroenterol Mex 2007; 72: 227-235.
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA. Risk factors for post-ERCP pancreatitis: A prospective multicenter study. Am J Gastroenterol 2006; 101: 139-147.
Aronson N, Flamm CR, Bohn RL, Mark DH, Speroff T. Evidence-based assessment: Patient, procedure, or operator factors associated with ERCP complications. Gastrointest Endosc 2002; 56 (6 Suppl): S294-302.
Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: A prospective series of claims to insurance covering public hospitals. Endoscopy 1999; 31: 125-130.
Sherman S, Lehman GA. ERCP and endoscopic sphincterotomy induced pancreatitis. Pancreas 1991; 6: 350-367.
Sherman S, Lehman GA. Sphincter of Oddi dysfunction: Diagnosis and treatment. J Pancreas 2001; 2: 382-400.
Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, Leandro G, Leo P, De Maio G, Perri F. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002; 56: 488-495.
Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-1524.
Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003; 57: 219-294.
Singh P, Das A, Isenberg G, Wong RC, Sivak MV, Agrawal D, Chak A. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitits? A meta-analysis of controlled trials. Gastrointest Endosc 2004; 60: 544-550.
Sherman S, Hawes RH, Savides TJ, Gress FG, Ikenberry SO, Smith MT, Zaidi S, Lehman GA. Stent-induced pancreatic ductal and parenchymal changes: Correlation of endoscopic ultrasound with ERCP. Gastrointest. Endosc 1996; 44: 276-282.
Mallery JS, Baron TH, Gominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Leighton JA, Raddawi HM, Varg JJ , Waring JP, Fanelli RD, Wheeler-Harbough J, Eisen GM, Faigel DO; Standards of Practice Committee. American Society for Gastrointestinal Endoscopy. Complications of ERCP. Gastrointestinal Endoscopy 2003; 57: 633-638.
Reddy N, Wilcox M, eloubeidi MA, Tamhane A, Varadarajulu S. Protocol based medical management of post-ERCP pancreatitis. J Gastroenterol Hepatol 2008; 23: 385-392.